Effect of GSK-3 overactivation on neurofilament phosphorylation

Abstract

In this study, we studied the effect of glycogen synthase kinase-3 (GSK-3) overactivation on neurofilament phosphorylation in cultured cells. After N2a cells were treated with the specific inhibitor (wortmannin) of phosphoinositol-3 kinase (PI-3K) or treated with wortmannin and the specific inhibitor (LiCl) of glycogen synthase kinase-3 (GSK-3), GSK-3 activity and neurofilament phosphorylation were detected by using GSK-3 activity assay, Western blots and immunofluoresence. Our results showed that after treatment of N2a cells with wortmannin for 1 h, overactivation of GSK-3 caused a reduced staining with antibody SMI32 and an enhanced staining with antibody SMI31. When N2a cells were treated with wortmannin and LiCl, the activity of GSK-3 was reduced substantially. At the same time, the phosphorylation of neurofilament was also reduced. The study demonstrated that overactivation of GSK-3 induced hyperphosphorylation of neurofilament and suggested thatin vitro overactivation of GSK-3 resulted in neurofilament hyperphosphorylation and this may be the underlying mechanism for Alzheimer's disease.

Keywords

glycogen synthase kinase-3 (GSK-3) / neurofilament / Alzheimer's disease

References

[1] DrewesG, Lichtenberg-KraagB, DoringF, et al.. Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer-like state. EMBO J, 1992, 11(6): 2131-2131

[2] MandelkowE M, DrewesG, BiernatJ, et al.. Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau. FEBS Lett, 1992, 314(3): 315-315

[3] YangS D, SongJ S, YuJ S, et al.. Protein kinase FA/GSK-3 phosphorylates tau on Ser235-Pro and Ser404-Pro that are abnormally phosphorylated in Alzheimer's disease brain. J Neurochem, 1993, 61(5): 1742-1742

[4] IshiguroK. Involvement of tau protein kinase in amyloid-beta-induced neurodegeneration. Rinsho Byori, 1998, 46(10): 1003-1003

[5] DelcommenneM, TanC, GrayV, et al.. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase. Proc Natl Acad Sci USA, 1998, 95(19): 11211-11211

[6] BillingsleyM L, KincaidR L. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration. Biochem J, 1997, 1: 323-323

[7] PeiJ J, TanankaT, TungYC, et al.. Distribution, levels, and activity of glycogen synthase-3 in the Alzheimer disease brain. J Neuropathol Exp Neurol, 1997, 56: 70-70

[8] WangJ, TungY C, WangY, et al.. Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS Lett, 2001, 507(1): 81-81

[9] BettsJ C, BlackstockW P, WardM A, et al.. Identifi cation of phosphorylation sites on neurofilament proteins by nanoelectrospray mass spectrometry. J Biol Chem, 1997, 272(20): 12922-12922

[10] HuY Y, HeS S, WangX C, et al.. Elevated levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett, 2002, 320(3): 156-156

[11] Straube-WestK, LoomisP A, OpalP, et al.. Alterations in neural intermediate filament organization: functional implications and the induction of pathological changes related to motor neuron disease. J Cell Sci, 1996, 109: 2319-2319